跳至主要内容
临床试验/NCT01320774
NCT01320774已完成不适用

Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris

LEO Pharma1 个研究点 分布在 1 个国家目标入组 588 人开始时间: 2011年4月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
LEO Pharma
入组人数
588
试验地点
1
主要终点
Handling of Daivobet® Gel

研究概览

简要总结

The purpose of this observational study is to evaluate the efficacy, tolerability, quality of life and handling of Daivobet® Gel by both physician and patient in daily practise.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with light to moderate psoriasis vulgaris of trunk and extremities and treatment with Daivobet® Gel was planned anyway

排除标准

  • Previous therapy with Daivobet® Gel
  • Systemic therapy of psoriasis vulgaris
  • Contraindications of Daivobet® Gel in the German package insert

结局指标

主要结局

Handling of Daivobet® Gel

时间窗: After appr 4 weeks

Compared to previous topical treatment: Time required for application (previous treatment versus present treatment), time required until dressing is possible (previous treatment versus present treatment)

次要结局

  • Quality of life(4 weeks)
  • Physician's global Assessment of psoriasis vulgaris(4 weeks)
  • Side effects(4 weeks)

研究者

发起方
LEO Pharma
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Efficacy, Tolerability and Handling of Daivobet® Gel... | 临床试验